Our study showed a higher prevalence of positive results of anti-SARS-CoV-2 antibodies in children with JIA compared to the control group (IgA 29.2% vs. 6.5%, IgG: 24.6% vs. 12.9%, respectively). The gene discussed is CD79A; the disease is juvenile idiopathic arthritis.